Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes. (Record no. 20669571)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01975 a2200565 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516030105.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201106s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1474-4465 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S1474-4422(11)70020-5 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Coles, Alasdair J |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20110615 |
| 245 00 - TITLE STATEMENT | |
| Title | Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Lancet. Neurology |
| Date of publication, distribution, etc. | Apr 2011 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 338-48 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adjuvants, Immunologic |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Alemtuzumab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Neoplasm |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon beta-1a |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-beta |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kaplan-Meier Estimate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Multiple Sclerosis, Relapsing-Remitting |
| General subdivision | therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Single-Blind Method |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fox, Edward |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vladic, Anton |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gazda, Suzanne K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brinar, Vesna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Selmaj, Krzysztof W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bass, Ann Doan-Do |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wynn, Daniel R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Margolin, David H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lake, Stephen L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moran, Susan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Palmer, Jeffrey |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smith, M Shelton |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Compston, D Alastair S |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Lancet. Neurology |
| Related parts | vol. 10 |
| -- | no. 4 |
| -- | p. 338-48 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1474-4422(11)70020-5">https://doi.org/10.1016/S1474-4422(11)70020-5</a> |
| Public note | Available from publisher's website |
No items available.